The Advanced Therapeutics department - One big happy family!

Advanced Therapeutics, a translational research department within the BC Cancer Agency, provides anticancer drug development capabilities which are focused on the critical need to rapidly establish the therapeutic value of emerging intervention strategies through validated assessments in preclinical models of cancer and in patients. Advanced Therapeutics comprises research scientists and clinical researchers (Drs. Bally, Waterhouse, Yapp, Wasan, Ng, Gelmon, Klasa, Chi, Chia, Gill, Laskin, Kollmansberger, Murray, Thiessen, Connors, O Reilly) in Medical Oncology who receive strong collaborative support from Pathology (Drs. Huntsman and Gascoyne) and other research units (Drs. Gleave, Gunns, Dunn, Jia, Roberge and Anderson). Under the co-leadership of a scientific research head (Dr. Bally) and a clinical research head (Dr. Gelmon), Advanced Therapeutics has established a strong multidisciplinary program of grant and industry funded research projects and clinical trials. The Department of Advanced Therapeutics focuses on discovering and developing improved therapeutic treatments for human malignancies.